Search

Search Constraints

You searched for: Author/Creator Carey, Mark

Search Results

1. 2022-RA-1068-ESGO Canadian practice patterns of primary treatment in advanced (stage III-IV) low grade serous ovarian carcinoma. (20th October 2022)

3. BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. Issue 3 (31st January 2013)

5. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Issue 8 (August 2022)